Asangani, Irfan A.
Dommeti, Vijaya L.
Wang, Xiaoju
Malik, Rohit
Cieslik, Marcin
Yang, Rendong
Escara-Wilke, June
Wilder-Romans, Kari
Dhanireddy, Sudheer
Engelke, Carl
Iyer, Mathew K.
Jing, Xiaojun
Wu, Yi-Mi
Cao, Xuhong
Qin, Zhaohui S.
Wang, Shaomeng
Feng, Felix Y.
Chinnaiyan, Arul M.
Article History
Received: 30 May 2013
Accepted: 5 March 2014
First Online: 23 April 2014
Competing interests
: A.M.C. serves as an advisor to Hologic, Life Technologies and Ventana/Roche and has formally served as an advisor to GSK and Constellation Pharmaceuticals. A.M.C. and S.W. are co-founders of Oncofusion Therapeutics, which is developing novel BET bromodomain inhibitors.